Back

Quantitative assessment of pericardial delayed hyperenhancement: have we finally found an objective criteria to diagnose and treat recurrence?

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Pericardial disease - Tumours of the heart Pericardial and myocardial disease, other ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Arnav Kumar

University of Texas Medical Branch, Galveston (United States of America)

11 More presentations in this session

Presentation thumbnail
Doctor A. Mager (Petah Tikva, IL)
Abstract
Presentation thumbnail
Assistant Professor M. Noutsias (Berlin, DE)
Abstract Slides
Presentation thumbnail
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Doctor G. Chalikias (Alexandroupolis, GR)
Abstract Slides
Presentation thumbnail
Doctor G. Lazaros (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Pericardial disease - Tumours of the heart

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
New guidelines in pericardial diseases: what is the role of multimodality imaging? - discussion
12 December 2025
thumbnail
Congress Presentation
Multidisciplinary approach to managing recurrent pericardial effusion in cancer patients: insights from a 5-year single-center experience
20 June 2025
thumbnail
Webinar
Heart failure imaging innovations : don't lag behind
15 March 2022
thumbnail
Congress Presentation
Recurrent cardiac sarcoidosis after orthotopic cardiac transplant - Not a cure even with immunosuppressive therapy
8 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources